![glp-1 agonist in esrd Repurposing Diabetes Therapies CKD: Mechanistic Insights, Clinical Outcomes and Safety of SGLT2i and RAs glp-1_analogs [TUSOM | Pharmwiki]](https://www.mdpi.com/pharmaceuticals/pharmaceuticals-18-01130/article_deploy/html/images/pharmaceuticals-18-01130-g006-550.jpg)
glp-1 agonist in esrd Repurposing Diabetes Therapies CKD: Mechanistic Insights, Clinical Outcomes and Safety of SGLT2i and RAs glp-1_analogs [TUSOM | Pharmwiki]
USD20.02
USD59.02
Pay in 4 interest-free payments of $5.00 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Oct 23 - Oct 28
![glp-1 agonist in esrd Repurposing Diabetes Therapies CKD: Mechanistic Insights, Clinical Outcomes and Safety of SGLT2i and RAs glp-1_analogs [TUSOM | Pharmwiki]](https://tmedweb.tulane.edu/pharmwiki/lib/exe/fetch.php/glp1.png?w=600&tok=baf39c)
![glp-1 agonist in esrd Repurposing Diabetes Therapies CKD: Mechanistic Insights, Clinical Outcomes and Safety of SGLT2i and RAs glp-1_analogs [TUSOM | Pharmwiki]](https://ars.els-cdn.com/content/image/1-s2.0-S1262363625000369-gr1.jpg)
![glp-1 agonist in esrd Repurposing Diabetes Therapies CKD: Mechanistic Insights, Clinical Outcomes and Safety of SGLT2i and RAs glp-1_analogs [TUSOM | Pharmwiki]](https://ajkdblog.org/wp-content/uploads/2026/01/Yau-VA.jpg)
![glp-1 agonist in esrd Repurposing Diabetes Therapies CKD: Mechanistic Insights, Clinical Outcomes and Safety of SGLT2i and RAs glp-1_analogs [TUSOM | Pharmwiki]](https://lookaside.fbsbx.com/lookaside/crawler/media/?media_id=10159731329369032)
:max_bytes(150000):strip_icc()/GettyImages-2169095535-f8d8276415dd4300a867a1f8b7de098f.jpg)
/assets/images/provider/photos/2764437.jpeg)
